Publication | Closed Access

1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: A novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and Alzheimer's diseases

Medicinal Chemistry1-N-substituted Thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolinesBiochemistryMedicineNatural SciencesRational Drug DesignPharmacological AgentNeuropharmacologyNeurologyNovel CholinesterasePharmacologyInhibitory ActivityDrug Discovery